Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

Discover Series: Diabetes

What would you discover to help a child? At The Kids, our researchers are committed to Type 1 Diabetes research that makes a real difference.

The Cashew Study

Does eating cashew nut spreads in the first year of life reduce the chances a baby will develop a cashew nut food allergy?

Research results

Many of the Centre's researchers have been responsible for discovering and contributing to real game-changers, making a difference to children with diabetes.

Research

ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents

Citation: Libman I, Haynes A, Lyons S, Pradeep P, Rwagasor E, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and

Publications

Browse the published work of the Centre's researchers

News & Events

Perth's active T1D community

Despite the unseasonal weather, good turnouts were recorded for recent events organised by PMH and Diabetes WA.

Research

Resilience and Diabetes 2 (the RAD2 study)

Investigators: Anna Hunt, Ashleigh Lin  Stress and anxiety are significant problems in children and adolescence with type 1 diabetes. Not only do

Research

Control of mitophagy initiation and progression by the TBK1 adaptors NAP1 and SINTBAD

Mitophagy preserves overall mitochondrial fitness by selectively targeting damaged mitochondria for degradation. The regulatory mechanisms that prevent PTEN-induced putative kinase 1 (PINK1) and E3 ubiquitin ligase Parkin (PINK1/Parkin)-dependent mitophagy and other selective autophagy pathways from overreacting while ensuring swift progression once initiated are largely elusive. 

Research

Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE

The pivotal phase 3 EPITOPE trial, a 12-month, double-blind, placebo-controlled study of epicutaneous immunotherapy with the VIASKIN patch containing 250 μg of peanut protein (VP250), previously reported significant treatment response versus placebo in peanut-allergic toddlers aged 1 through 3 years.

News & Events

Ten Day Continuous Glucose Monitoring study – now recruiting

The Children’s Diabetes Centre is now recruiting for a new continuous glucose monitoring study.